AzTrials
AzTrials

Healthy IndividualsFIRE-Diet-MNCT06711614

FIRE-Diet: Food as an Intervention to Reduce the Effects of Woodsmoke Exposure on Respiratory Health

A study testing Intervention Diet in people with Healthy Individuals, run by University of British Columbia at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Research suggests that consuming more fatty fish, fruits, and vegetables could potentially shield the lungs from the negative impacts of air pollution. The research team will look at whether a dietary intervention aimed at increasing intake of these foods can protect the lungs from woodsmoke as the air pollutant and… Read more about this study

Who is it for?
Ages 19 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Individuals
What is being tested?
Intervention Diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteCanada
Study dates
17 Jun 2025to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy, and specifically with no respiratory disease
  • Not taking any supplements, or willing to abstain from supplement use for 4-weeks prior to study start and the whole duration of the study,
  • Must currently consume, on average, less than 2 servings of fish per week and fewer than 5 servings of fruits and vegetables per day based on screening questionnaires.
  • Must have a null GSTM1 genotype determined at screening.
  • Must be able to provide a sufficient sputum sample during the screening visit.

Who cannot join

  • Pregnant or planning to become pregnant during the study period.
  • Health conditions that would pose an unacceptable risk of dietary change, or conditions that are uncontrolled based on principal investigator's judgement.
  • Actively attempting to lose weight.
  • Frequent wood smoke exposure (e.g. at home or employment).
  • Unable to store provided meals and food safely.
  • Food allergies/intolerance or food aversion preventing adherence to the intervention diet, or unwillingness/medically unable to adjust diet in line with the intervention.
Show all 9Show fewer
  • Relocation during the study period to an area which will prevent food delivery.
  • History of smoking tobacco, marijuana, or and other substance or vaping within the past 6 months, or having smoked the equivalent of 0.5 pack-years ever.
  • Body mass index (BMI) <18.5, as determined during the in-person screening visit.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • University of British Columbia

    Vancouver, British Columbia, V5Z 1M9

    Agustin Bueso, BSc, 604-875-4111 ext. 23177, agustin.bueso@ubc.ca

    Agnes CY Yuen, BSc, 604-875-4111 ext. 66455, agnes.yuen@ubc.ca

    Recruiting

Other trials in Canada

About this study

Research suggests that consuming more fatty fish, fruits, and vegetables could potentially shield the lungs from the negative impacts of air pollution. The research team will look at whether a dietary intervention aimed at increasing intake of these foods can protect the lungs from woodsmoke as the air pollutant and look into how this works.

Read the detailed description

This study aims to recruit 48 healthy adult volunteer participants (24 male and 24 female biologic sex assigned at birth) with no known respiratory diseases (as assessed by the study physician) who will breathe in woodsmoke while they are supported to eat a diet higher in fatty fish, fruits, and vegetables (the intervention diet), or not (the control diet).

All participants will undergo a screening visit to assess eligibility for the study. Once deemed eligible, they will experience three exposure visits: one fresh air (filtered air - FA) exposure and two woodsmoke (WS) exposures. The study will span a minimum duration of 15 weeks with 10 in-person visits to the site at Vancouver General Hospital, totaling approximately 34.5 hours. During these visits, participants will complete a series of questionnaires, sample collections (blood, urine, sputum (clumps of mucus that are coughed up from the lungs)), and lung function tests, in addition to the exposures mentioned above.

Off-site commitments will require participants to follow the recommended diet assigned at the time, complete some electronic questionnaires and breathing tests at home after exposures, and complete telephone calls with the study dietician (approximately 30-minute calls, weekly).

Participants will be provided with meal and grocery deliveries to meet intake goals specified by the study or a subsidized amount of groceries per week depending on the diet intervention assigned at that time.

Being tested
Intervention Diet, Control Diet
Keywords
Diet Intervention, EPA, DHA, Omega-3 fatty acids

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention DietOther

    Designed to increase Omega-3 Fatty Acids (Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA)), fruit, and vegetable intake, participants will receive grocery and meal deliveries for approximately 4-weeks via online ordering with dietician counselling.

  • Control DietOther

    Participants will receive weekly food subsidies for their groceries for 4-weeks (~equivalent to the subsidies to provide groceries in the Intervention arm) but are free to purchase whatever they wish. The participants will continue to have dietician counseling during this time.

Study groups in NCT06711614
Study groupRoleWhat they receive
Intervention Diet First, then Control DietOtherParticipants will complete ~4 weeks of the Intervention Diet, followed by a washout period of at least 4 weeks, then ~4 weeks of the Control Diet. At the end of each Diet period, participants will undergo a 2 hour controlled wood smoke exposure, following which outcome measures will be assessed.
Receives: Other: Intervention Diet; Other: Control Diet
Control Diet First, then Intervention DietOtherParticipants will complete ~4 weeks of the Control Diet, followed by a washout period of at least 4 weeks, then ~4 weeks of the Intervention Diet. At the end of each Diet period, participants will undergo a 2 hour controlled wood smoke exposure, following which outcome measures will be assessed.
Receives: Other: Intervention Diet; Other: Control Diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Within-individual change in sputum neutrophil %

    Within-individual change in sputum neutrophil %, compared across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  2. Within-individual change in sputum neutrophil activation and function

    Within-individual change in sputum neutrophil activation (expression of neutrophil activation cell surface markers, release of neutrophil elastase and myeloperoxidase), and neutrophil function (phagocytosis, intracellular oxidative burst, and extracellular trap formation) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks

  3. Within-individual change in airway resistance

    Within-individual change in airway resistance, as measured by impulse oscillometry (resonant frequency (Fres) and peripheral airway resistance (R5-R20)) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  4. Within-individual change in sputum biomarkers of inflammation

    Within-individual change in sputum biomarkers of inflammation (IL-6, IL-8, and TNF-alpha in sputum as well as fractional exhaled nitric oxide) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

Secondary outcomes (6)
  1. Within-individual change in sputum biomarkers/arbiters of inflammation

    Within-individual change in sputum biomarkers of inflammation (MCP-1, IL-4, IL-5, IL-13, protectins, maresins, resolvins) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  2. Within-individual change in upper airway (nasal) markers of neutrophil activation and function

    Within-individual change in biomarkers of neutrophil activation (myeloperoxidase, neutrophil elastase in nasal epithelial lining fluid) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  3. Within-individual change in upper airway (nasal) biomarkers/arbiters of inflammation

    Within-individual change in biomarkers of inflammation (including IL-6, IL-8, TNF-alpha, MCP-1, IL-4, IL-5, IL-13, protectins, resolvins, maresins in nasal epithelial lining fluid) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  4. Within-individual change in blood neutrophil %

    Within-individual change in blood neutrophil %, compared across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

  5. Within-individual change in blood neutrophil activation and function

    Within-individual change in blood neutrophil activation (expression of neutrophil activation cell surface markers, release of neutrophil elastase and myeloperoxidase), and neutrophil function (phagocytosis, intracellular oxidative burst, and extracellular trap formation) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks

  6. Within-individual change in spirometry

    Within-individual change in spirometry, as measured by (Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), and FEV1/FVC) across Intervention and Control Diet periods post wood smoke exposures.

    Measured: Across study duration, anticipated ~15 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2024
  2. Study start17 Jun 2025
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will be randomized to begin the study with the control diet (their usual diet) or the intervention diet (aimed at increasing intake of fatty fish high in omega-3 fatty acids, fruits, and vegetables) x \~4 weeks. After a washout period of at least 4 weeks the participant will complete the alternate assignment. At the end of each assignment (control or intervention diet) the participant will undergo a controlled exposure to wood smoke x 2 hours, following which lung health outcomes will be assessed as described.
Masking
Single blind
Who is masked
Investigator
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06711614
Sponsor's protocol ID
H23-03904
Acronym
FIRE-Diet-M
Status last verified
May 2025
First submitted
18 Oct 2024
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention Diet in people with Healthy Individuals, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Agustin Bueso (604-875-4111 ext. 21721, agustin.bueso@ubc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Within-individual change in sputum neutrophil % (time frame: Across study duration, anticipated ~15 weeks.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in